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Abstract: Abarema cochliacarpos (Gomes) Barneby & J.W. Grimes, Fabaceae, is a 
native species of Brazil popularly known as “barbatimão”, frequently found along the 
north coast of the state of Bahia. Local communities make an infusion from its stem bark, 
which is used to treat several diseases. This study aimed to evaluate the hepatotoxicity of 
A. cochliacarpos extracts in mice Mus musculus. The bark infusion and hydroalcoholic 
extract were administered nasogastrically into two groups of eight animals (four male 
and four female each). After 45 days all mice were killed and the livers were collected 
for further histological analysis. Hepatic steatosis, congestion of the hepatic vessels and 
presence of macrophages and lymphocytes infi ltrates in the liver, were observed in both 
group of animals, additionally animals that received the stem bark infusion presented 
an accumulation of pigments. None of the animals belonging to the negative control 
group showed any of the symptoms described above. In conclusion, the hydroalcoholic 
extract and infusion of A. cochliacarpos stem bark were proven to cause intoxication 
in mice. The hepatotoxicity of the infusion was more aggressive in females. Further 
studies are necessary to isolate compounds responsible for the toxic characteristics of A. 
cochliacarpos.
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Introduction
 According to the World Health Organization, 
80% of the world’s population use medicinal plants to treat 
health problems. In Brazil, the knowledge left behind by 
the Indigenous and African communities about medicinal 
plants is a powerful alternative for the treatment of several 
diseases. (Almeida, 2000; Albuquerque et al., 2007). 
Despite the pharmacological properties of these plants, its 
indiscriminate use can lead to serious asymptomatic effects, 
such as carcinogenesis, hepatotoxicity and nephrotoxicity, 
as it has been described for extracts obtained from 
Symphytum offi cinale L., Boraginaceae (Ramos, 2005).
 Abarema cochliacarpos (Gomes) Barneby & J.W. 
Grimes, popularly known as "barbatimão", "babatemão" 
and "barbatião", belongs to the Fabaceae family and it is 
a medium size tree growing up to 8 m high (Santos, 2004; 
Silva et al., 2011). It is commonly found along the north 
coast of the state of Bahia, where local communities use 
its bark infusion to treat symptoms of gastritis, diarrhea, 
infl ammation, uterine bleeding, leucorrhea, vaginal 
irritation, sores and ulcers (Fenner et al., 2006; Silva et 
al., 2006; Santos et al., 2007; Agra et al., 2008; Silva et al., 
2009; Silva et al., 2010a,b).
 Silva and collaborators (2009) studying the 
chemical composition of the A. cochliacarpos reported 
the presence of saponins, catechins, tannins, phenols 
and anthraquinones in the extracts. Recently, Silva et 
al. (2011) evaluated the anti-infl ammatory activity of A. 
cochliacarpos methanolic and butanolic extracts on Wistar 
mice and showed that the treatment with A. cochliacarpos 
extracts signifi cantly decreased the symptoms of the disease 
on the intestinal mucosa. However, Melo and co-workers 
(2008) showed that the administration of either saponin or 
tannin fractions obtained from Mascagnia rigida Griseb., 
Malpighiaceae, caused an increase of the CK-MB enzyme, 
highlighting that M. rigida has the ability to cause damage 
to myocardial fi bers.
 According to Cotran et al. (2000), the liver can 
be stricken by a variety of metabolic, toxic, microbial, 
circulatory and neoplastic illnesses. A liver injury may be 
visualized through the accumulation of fat droplets within 
hepatocytes (steatosis), badly stained and mummifi ed 
hepatocytes, necrosis, parenchyma with clumps of 
infl ammatory cells (infl ammation), yellowish skin caused 
by bilirubin retention (jaundice), or parenchymal damage 
caused by the destruction of hepatocytes (liver failure and 
cirrhosis).
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 The increase in liver fat, even without any alcohol 
consumption, can cause cirrhosis, and in some cases even 
liver cancer. The steatohepatitis affects children, but can 
also affect adults between the ages of 20 and 60 years 
old. In general, women are more affected by this disease 
(Campos, 2007).
 The low output caused by veno-occlusive diseases 
and other liver damages can lead to portal hypertension 
followed by venous congestion and dilation on the 
microcirculation, thereby altering the transport of nutrients 
and hepatotrophic factors. Liver sinusoidal lesions can 
also lead to fibrosis and cirrhosis, causing the death of the 
organ (Aguiar et al., 2011).
 Liver cells secrete phospholipids which accounts 
for up to 2% of the bile weight (e.g. lecithin) through 
the membrane-associated protein transporter MDR3 
(Multidrug Resistance Protein 3). Cholesterol is also 
secreted and accounts for up to 4% of the bile weight. 
Cholesterol binds to two specific transporters (ABCG5/
G8), and is secreted along with the bile salts (Ikonen, 
2006).
 The inflammation is an immune system response 
against the infection that arises over the course of the liver 
injury. It is characterized by the infiltration or clusters of 
white blood cells scattered throughout the lobes of the 
liver parenchyma. Regarding liver poisoning, in a survey 
about drug poisoning among the elderly, Bernardes et 
al. (2005) showed that aging process is associated with 
pharmacokinetic and pharmacodynamic changes, such 
as body composition, basal metabolism, hepatic blood 
flow and glomerular filtration rate. Therefore, drugs 
prescriptions for the elderly should take into account 
aspects such as decreased muscle mass, which reduces the 
distribution of the drug, as well as a narrow therapeutic 
window, which makes therapeutic doses much closer to 
toxic doses.
 Since the medicinal properties of A. 
cochliacarpos are well known and described by 
local communities, this study aimed to evaluate the 
hepatotoxicity of its extracts on mice Mus musculus.
Materials and Methods
Plant material
 Drying, selection and storage conditions were 
performed according to the rules described in Campos 
(1991) and the Resolution-RDC No. 17 of 24th February 
2000. Abarema cochliacarpos (Gomes) Barneby & J.W. 
Grimes, Fabaceae, stem bark was collected in the ecological 
park of Instituto de Desenvolvimento Sustentável do Litoral 
Norte da Bahia, located in Vila de Sauípe, coordinates 12º 
33'16 " South latitude and 037 º 55'27'' West longitude 
(Megallan, GPS 315), Mata de São João, Bahia, Brazil. 
The voucher specimen (51540) was identified by Dra. 
Hortensia Pousada Bautista and is stored at Radambrasil 
(HRB) herbarium, Salvador, Bahia. The plant material was 
collected in the morning and transported on trays lined 
with paper towels, as described by Campos (1991). The 
material was dried in an oven at 40-45 °C for twenty days. 
Dry weight was determined using an analytical balance 
(Mettler Toledo AG-285), until no variation in the weight 
was observed.
Preparation of the infusion 
 Dried stem bark (20 g) was used to prepare the 
infusion by adding 125 mL of boiling distillated water 
during 15 min. Dilutions of this infusion (12.5, 25 and 
50% v/v) were prepared with distillated water.
Preparation of the crude extract
 The dried and powdered stem bark (68 g) were 
extracted exhaustively (three consecutive times) by 
maceration, using ethanol 70% (200 mL), and leaving at 
room temperature, in the dark, for two days. The combined 
extract was filtered using filter paper (Qualy, 14 μm) 
and a vacuum pump (Marconi, MA 057/1). It was then 
concentrated under reduced pressure at 40 °C (Heidolph, 
Taiff 2100). Finally, the crude extract was lyophilized 
(Labconco Mark) to remove the solvent completely.
Animals
 The number of swiss mice used in this work was 
established in accordance with the methodology described 
by Oliveira & Andrade (2001). Twenty adult swiss mice, 
supplied by the Laboratory of Environmental Studies at 
the Catholic University of Salvador, were divided into two 
groups of eight animals (four males and four females) plus 
a negative control group of four animals (two males and 
two females). Animals used in this experiment were 2.5 
month old, weighing approximately 30 g each and were fed 
with rodent chow. Negative control animals were chosen 
randomly. Experiments using animals were approved of 
by the Ethics Committee on the Use of Animals in the 
School of Veterinary Medicine, Federal University of 
Bahia, protocol 05/2011.
Hepatotoxicity assay
 Mice were deprived of food and water for 3 
h prior to the administration of the infusion and crude 
extract dilutions. They were anesthetized with ether and 
a 5 cm of a nasogastric tube was introduced through their 
mouths into their stomachs. Within the first group of 
animals, four groups of two animals each (one male and 
one female) were assigned to receive different dilutions 
of the infusion. An aliquot of 1 mL of the bark infusion 
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and its dilutions (12.5, 25 and 50% v/v) were administered 
by using nasogastric tubes and disposable syringes. The 
administration of the infusion was performed via oral 
route as this is the traditional way of taking the infusion by 
local population where the plant was collected. Similarly, 
the second group of animals was subdivided in four groups 
of two animals each (one male and one female). Different 
concentrations (125, 250, 500 and 1000 mg/mL) of the 
crude extract were prepared in water and 1 mL of each 
solution was administered using nasogastric tubes and 
disposable syringes. In total, four animals were used as 
negative control.
Histological studies
 Histology slides were prepared according to the 
method described by Young & Heath (2001). Briefly, we 
used tissue samples from the liver of each animal and fixed 
in 37% formaldehyde, then submerged into paraffin. Tissue 
slices (5 μm) were obtained and stained with hematoxylin-
eosin in accordance with the standard procedures for 
histological evaluation described by Timm (2005). All 
tissue slices were examined in an Olympus Color 3 (BX 
51) microscope. Image-Pro-Plus® software was used 
to characterize histopathological changes. Besides the 
histological studies, the toxicity of A. cochliacarpos 
infusion and crude extract were evaluated by observing 
some characteristics in the animals’ behavior, such as 
breathing, feeding, abdominal aspect and locomotion. 
Results and Discussion
 Abarema cochliacarpos (Gomes) Barneby & 
J.W. Grimes, Fabaceae, infusion has been used by many 
communities in the treatment of several gastrointestinal 
disorders. However, indiscriminate use of plants in popular 
medicine can lead to serious asymptomatic effects (Ramos, 
2005). After the administration of A. cochliacarpos bark 
infusion and crude extract in Swiss mice, changes in 
locomotion, breathing, feeding and abdominal aspect were 
observed. Steatosis was observed in the group of animals 
treated with the bark infusion and with the crude extract 
of A. cochliacarpos, evidenced by the accumulation of 
fat droplets within the hepatocytes (Figure 1). Steatosis, 
also known as fatty change, fatty degeneration or adipose 
degeneration, is characterized by the presence of fat 
droplets on the interior of the liver hepatocytes. This process 
is often associated with accumulations of lymphocytes 
and macrophages (inflammatory cell infiltration). Liver 
secretes bile on fats through ABCG5/G8 carriers, and this 
is the main form of excretion of cholesterol in the human 
body (Ikonen, 2006). 
Figure 1. Effect of bark infusion and crude extract of Abarema cochliacarpos on liver of Swiss mice (steatosis). Histological 
appearance of animals treated with crude extract (A, male; C, female) and bark infusion (B, female; D, male) show accumulation 
of fat droplets (steatosis). Stained with hematoxylin and eosin. Original magnification: 100x.
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 These results are in agreement with Brito et al. 
(2001) which reported the effect of Stryphnodendron 
obovatum (family Fabaceae, subfamily Mimosoideae), 
also known as barbatimão, in young cattle. It was observed 
anatomical and histological changes associated with 
intoxication, like epithelial detachment and congestion, 
ulcers and focal hemorrhages throughout the digestive 
tract. According to Ramos (2005), indiscriminate use of 
Symphytum officinale L. extract and infusion can lead to 
several liver diseases. Rebecca and co-workers (2003) 
reported that Stryphnodendron aqueous extract hampers 
hepatic metabolism in three different ways: during 
oxidative phosphorylation, inhibition of mitochondrial 
electron transport and ATP synthesis inhibition.
 Both group of animals presented congestion of 
the hepatic vessels (Figure 2) and presence of macrophages 
and lymphocytes infiltrates (Figure 3C, D and E). 
However, presence of pigments in liver parenchyma was 
just observed in animals treated with the crude extract 
(Figure 3A and B). None of the animals in the negative 
control group showed hepatic steatosis, accumulation of 
pigments, congestion of the hepatic vessels, presence of 
macrophages and lymphocytes infiltrates.
 According to Silva and collaborators (2010) 
A. cochliacarpos extracts are effective as healing, anti-
ulcerogenic and analgesic. Silva (2004) described that 
extracts and infusions prepared with A. cochliacarpos 
stem bark induced hepatitis, steatosis and hepatic vessels 
congestion in agreement with results found in this 
study. Audi and colleagues (1999) reported the use of S. 
adstringens extracts in the treatment of induced gastric 
lesions in mice.
 Phytochemical investigation on A. cochliacarpos 
has shown presence of saponins, catechins, tannins, 
phenols and anthraquinones, which may be responsible 
for the toxic and pharmacological properties of this plant 
(Santos et al., 2006; Silva et al., 2009).
Figure 2. Effect of bark infusion and crude extract of Abarema cochliacarpos on liver of Swiss mice (congestion of the hepatic 
vessels). Histological appearance of animals treated with crude extract (A, female; C and E, male) and bark infusion (B, female; D, 
male) show congestion of the hepatic vessels. Stained with hematoxylin and eosin. Original magnification: 100x.
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Conclusion
 Both A. cochliacarpos bark infusion and crude 
extract caused intoxication in mice, where histological 
studies showed the presence of steatosis, accumulation of 
pigments, congestion of the hepatic vessels and presence 
of macrophages and lymphocytes infiltrates in the liver. It 
was observed that intoxication was more aggressive among 
females. Even though several studies have been published 
regarding A. cochliacarpos activity in the treatment of 
different diseases, this report describes its hepatotoxicity 
and these results are especially important because many 
poor communities use A. cochliacarpos infusion to provide 
treatments for their illnesses. 
 Further phytochemical analysis of the bark 
infusion and crude extract is necessary to separate 
and identify chemical compounds responsible for the 
hepatotoxicity of A. cochliacarpos in mice Mus musculus.
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Figure 3. Effect of bark infusion and crude extract of Abarema cochliacarpos on liver of Swiss mice (pigments, macrophages 
and lymphocytes infiltrates). Histological appearance of animals treated with crude extract show presence of pigments in the liver 
parenchyma (A, male; B, female) and presence of macrophages and lymphocytes infiltrates (C, male; E, female). Animals treated 
with bark infusion (D, female) presence of macrophages and lymphocytes infiltrates. Stained with hematoxylin and eosin. Original 
magnification: 100X.
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